Group structure
6 companies in 3 countries
Canada1
Malaysia1
Netherlands1
Headquarters not stated3
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Loading…
6 companies in 3 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1–25 of 129
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AQUAFLOR500 G / Kg · Drug Premix | Florfenicol | Canada | Marketed | 1997 |
| AROVYN100 mg / ml · Solution | Tulathromycin | Canada | Authorised | |
| BANAMINE50 mg / ml · Solution | Flunixin | Canada | Marketed | 1979 |
| BANAMINE50 mg / ml · Solution | Flunixin | Canada | Marketed | 2017 |
| BORGAL200 mg / ml + 40 mg / ml · Solution | Sulfadoxine, Trimethoprim | Canada | Marketed | 1986 |
| BRAVECTO1400 mg · Tablet (Chewable) | Fluralaner | Canada | Marketed | 2014 |
| BRAVECTO1400 mg / 5 ml · Solution | Fluralaner | Canada | Marketed | 2018 |
| BRAVECTO500 mg · Tablet (Chewable) | Fluralaner | Canada | Marketed | 2014 |
| BRAVECTO112.5 mg / 0.4 ml · Solution | Fluralaner | Canada | Marketed | 2017 |
| BRAVECTO112.5 mg / 0.4 ml · Solution | Fluralaner | Canada | Marketed | 2018 |
| BRAVECTO250 mg / 0.89 ml · Solution | Fluralaner | Canada | Marketed | 2018 |
| BRAVECTO500 mg / 1.79 ml · Solution | Fluralaner | Canada | Marketed | 2018 |
| BRAVECTO112.5 mg · Tablet (Chewable) | Fluralaner | Canada | Marketed | 2014 |
| BRAVECTO1000 mg · Tablet (Chewable) | Fluralaner | Canada | Marketed | 2014 |
| BRAVECTO250 mg / 0.89 ml · Solution | Fluralaner | Canada | Marketed | 2017 |
| BRAVECTO1000 mg / 3.57 ml · Solution | Fluralaner | Canada | Marketed | 2018 |
| BRAVECTO250 mg · Tablet (Chewable) | Fluralaner | Canada | Marketed | 2014 |
| BRAVECTO500 mg / 1.79 ml · Solution | Fluralaner | Canada | Marketed | 2017 |
| BRAVECTO ONE400 mg · Tablet (Chewable) | Fluralaner | Canada | Marketed | 2021 |
| BRAVECTO ONE100 mg · Tablet (Chewable) | Fluralaner | Canada | Marketed | 2021 |
| BRAVECTO ONE560 mg · Tablet (Chewable) | Fluralaner | Canada | Authorised | |
| BRAVECTO ONE200 mg · Tablet (Chewable) | Fluralaner | Canada | Marketed | 2021 |
| BRAVECTO ONE45 mg · Tablet (Chewable) | Fluralaner | Canada | Marketed | 2021 |
| BRAVECTO QUANTUM2.51 g / vial · Powder For Suspension | Fluralaner | Canada | Marketed | 2025 |
| CANINSULIN40 unit / ml · Suspension | Insulin pork | Canada | Marketed | 2014 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 111 | 81 | 30 | CompaniesAll medicines |
| European Union (EMA) | 18 | 0 | 18 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Keep Intervet’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.